Merck & Company (MRK)
:MRK
US Market
Advertisement

Merck & Company (MRK) Ratios

Compare
14,422 Followers

Merck & Company Ratios

MRK's free cash flow for Q3 2025 was $0.82. For the 2025 fiscal year, MRK's free cash flow was decreased by $ and operating cash flow was $0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.66 1.25 1.47 1.27 1.02
Quick Ratio
1.44 1.00 1.23 1.02 0.79
Cash Ratio
0.63 0.27 0.52 0.34 0.30
Solvency Ratio
0.38 0.06 0.29 0.24 0.16
Operating Cash Flow Ratio
0.60 0.51 0.79 0.59 0.38
Short-Term Operating Cash Flow Coverage
12.15 9.48 9.81 5.85 1.59
Net Current Asset Value
$ -11.81B$ -36.87B$ -27.38B$ -37.17B$ -38.42B
Leverage Ratios
Debt-to-Assets Ratio
0.37 0.34 0.28 0.31 0.35
Debt-to-Equity Ratio
0.80 0.97 0.67 0.87 1.26
Debt-to-Capital Ratio
0.44 0.49 0.40 0.46 0.56
Long-Term Debt-to-Capital Ratio
0.44 0.47 0.38 0.45 0.50
Financial Leverage Ratio
2.14 2.84 2.37 2.77 3.62
Debt Service Coverage Ratio
9.04 2.14 6.67 5.09 1.17
Interest Coverage Ratio
19.76 2.58 20.17 17.00 7.31
Debt to Market Cap
0.18 0.12 0.11 0.17 0.16
Interest Debt Per Share
17.04 14.35 12.50 13.40 12.89
Net Debt to EBITDA
0.89 4.26 0.84 1.40 2.33
Profitability Margins
Gross Profit Margin
78.32%73.17%70.63%72.02%67.20%
EBIT Margin
35.44%5.05%29.36%30.15%16.12%
EBITDA Margin
40.75%11.49%35.95%36.75%24.52%
Operating Profit Margin
36.42%4.91%32.72%28.14%14.63%
Pretax Profit Margin
33.96%3.14%27.74%28.50%21.17%
Net Profit Margin
29.63%0.61%24.49%26.79%17.02%
Continuous Operations Profit Margin
29.65%0.63%24.50%25.37%10.89%
Net Income Per EBT
87.24%19.32%88.29%94.02%80.39%
EBT Per EBIT
93.26%63.95%84.77%101.28%144.68%
Return on Assets (ROA)
17.11%0.34%13.30%12.35%7.72%
Return on Equity (ROE)
38.95%0.97%31.57%34.17%27.91%
Return on Capital Employed (ROCE)
28.33%3.65%22.84%16.75%9.46%
Return on Invested Capital (ROIC)
24.31%0.71%19.73%14.48%6.90%
Return on Tangible Assets
25.61%0.54%21.45%21.22%12.45%
Earnings Yield
8.33%0.13%5.17%6.73%3.58%
Efficiency Ratios
Receivables Turnover
5.30 5.81 6.27 5.28 5.73
Payables Turnover
3.36 4.11 4.08 2.96 3.15
Inventory Turnover
2.16 2.54 2.95 2.29 2.16
Fixed Asset Turnover
2.51 2.45 2.77 2.53 2.31
Asset Turnover
0.58 0.56 0.54 0.46 0.45
Working Capital Turnover Ratio
4.29 6.70 6.63 14.26 14.57
Cash Conversion Cycle
129.06 117.97 92.71 105.17 116.80
Days of Sales Outstanding
68.87 62.84 58.18 69.17 63.65
Days of Inventory Outstanding
168.87 143.91 123.92 159.46 169.13
Days of Payables Outstanding
108.68 88.77 89.39 123.46 115.98
Operating Cycle
237.74 206.74 182.10 228.64 232.77
Cash Flow Ratios
Operating Cash Flow Per Share
6.83 4.99 7.54 5.58 4.05
Free Cash Flow Per Share
5.22 3.51 5.81 3.82 2.20
CapEx Per Share
1.61 1.48 1.73 1.76 1.85
Free Cash Flow to Operating Cash Flow
0.76 0.70 0.77 0.68 0.54
Dividend Paid and CapEx Coverage Ratio
1.41 1.15 1.68 1.28 0.94
Capital Expenditure Coverage Ratio
4.25 3.37 4.35 3.17 2.19
Operating Cash Flow Coverage Ratio
0.41 0.36 0.62 0.43 0.32
Operating Cash Flow to Sales Ratio
0.27 0.22 0.32 0.29 0.25
Free Cash Flow Yield
5.68%3.22%5.24%4.98%2.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.97 778.71 19.35 14.86 27.92
Price-to-Sales (P/S) Ratio
3.57 4.73 4.74 3.98 4.75
Price-to-Book (P/B) Ratio
4.40 7.56 6.11 5.08 7.79
Price-to-Free Cash Flow (P/FCF) Ratio
17.57 31.09 19.10 20.07 35.44
Price-to-Operating Cash Flow Ratio
13.36 21.85 14.71 13.74 19.25
Price-to-Earnings Growth (PEG) Ratio
0.73 -7.98 1.75 0.17 -1.02
Price-to-Fair Value
4.40 7.56 6.11 5.08 7.79
Enterprise Value Multiple
9.65 45.41 14.02 12.23 21.72
Enterprise Value
253.04B 313.66B 298.92B 218.91B 221.07B
EV to EBITDA
9.67 45.41 14.02 12.23 21.72
EV to Sales
3.94 5.22 5.04 4.49 5.32
EV to Free Cash Flow
19.39 34.31 20.33 22.66 39.70
EV to Operating Cash Flow
14.83 24.12 15.65 15.52 21.56
Tangible Book Value Per Share
5.98 -0.60 1.81 -2.35 -3.73
Shareholders’ Equity Per Share
20.76 14.41 18.16 15.09 10.01
Tax and Other Ratios
Effective Tax Rate
0.13 0.80 0.12 0.11 0.19
Revenue Per Share
25.71 23.06 23.41 19.25 16.41
Net Income Per Share
7.62 0.14 5.73 5.16 2.79
Tax Burden
0.87 0.19 0.88 0.94 0.80
Interest Burden
0.96 0.62 0.94 0.95 1.31
Research & Development to Revenue
0.25 0.51 0.23 0.25 0.32
SG&A to Revenue
<0.01 0.14 0.13 0.16 0.17
Stock-Based Compensation to Revenue
0.01 0.01 <0.01 <0.01 0.01
Income Quality
0.90 35.63 1.31 1.14 1.45
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis